Cargando…

Controversies in Clostridium difficile testing

Recent reports of two nosocomial outbreaks of Clostridium difficile-associated disease caused by toxin A-deficient strains emphasize that these strains can cause disease. Laboratories using an assay that detects only toxin A as their primary diagnostic test risk misdiagnosis of cases or outbreaks in...

Descripción completa

Detalles Bibliográficos
Autor principal: Fedorko, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135516/
https://www.ncbi.nlm.nih.gov/pubmed/32287670
http://dx.doi.org/10.1016/S0196-4399(02)80020-4
_version_ 1783518073597198336
author Fedorko, Daniel P.
author_facet Fedorko, Daniel P.
author_sort Fedorko, Daniel P.
collection PubMed
description Recent reports of two nosocomial outbreaks of Clostridium difficile-associated disease caused by toxin A-deficient strains emphasize that these strains can cause disease. Laboratories using an assay that detects only toxin A as their primary diagnostic test risk misdiagnosis of cases or outbreaks in the institutions they serve. Repeat testing can account for a significant portion of a laboratory's C. difficile testing workload. Published data are available to support laboratory rules for rejection of repeat stool specimens within 7 days of an initial specimen. There are also substantial published data to support laboratory rejection of formed stools sent to the laboratory for C. difficile testing.
format Online
Article
Text
id pubmed-7135516
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71355162020-04-08 Controversies in Clostridium difficile testing Fedorko, Daniel P. Clin Microbiol Newsl Article Recent reports of two nosocomial outbreaks of Clostridium difficile-associated disease caused by toxin A-deficient strains emphasize that these strains can cause disease. Laboratories using an assay that detects only toxin A as their primary diagnostic test risk misdiagnosis of cases or outbreaks in the institutions they serve. Repeat testing can account for a significant portion of a laboratory's C. difficile testing workload. Published data are available to support laboratory rules for rejection of repeat stool specimens within 7 days of an initial specimen. There are also substantial published data to support laboratory rejection of formed stools sent to the laboratory for C. difficile testing. Published by Elsevier Inc. 2002-05-15 2002-07-25 /pmc/articles/PMC7135516/ /pubmed/32287670 http://dx.doi.org/10.1016/S0196-4399(02)80020-4 Text en Copyright © 2002 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Fedorko, Daniel P.
Controversies in Clostridium difficile testing
title Controversies in Clostridium difficile testing
title_full Controversies in Clostridium difficile testing
title_fullStr Controversies in Clostridium difficile testing
title_full_unstemmed Controversies in Clostridium difficile testing
title_short Controversies in Clostridium difficile testing
title_sort controversies in clostridium difficile testing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135516/
https://www.ncbi.nlm.nih.gov/pubmed/32287670
http://dx.doi.org/10.1016/S0196-4399(02)80020-4
work_keys_str_mv AT fedorkodanielp controversiesinclostridiumdifficiletesting